Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $7.36 USD
Change Today -0.08 / -1.08%
Volume 2.3M
OREX On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David J. Endicott

Director and Member of Nominating/Corporate Governance Committee, Orexigen Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 3 different industries.

See Board Relationships
49$6,931,528

Background*

Mr. David J. Endicott has been the President of Hospira Medical Devices at Hospira Inc. since March 10, 2014. Mr. Endicott served as a Corporate Vice President and President of Allergan Medical, Asia Pacific and Latin America at Allergan Inc. since April 2011. He served as Corporate Vice President and President of Allergan Medical at Allergan, Inc. since August 2010. He served as Corporate Vice President and President of Europe, Africa and Middle East at Allergan, Inc. ...

Read Full Background

Corporate Headquarters*

3344 North Torrey Pines Court
La Jolla, California 92037

United States

Phone: 858-875-8600
Fax: 858-875-8650

Board Members Memberships*

2012-Present
Director and Member of Nominating/Corporate Governance Committee

Education*

MBA
University of Southern California
Unknown/Other Education
Harvard Business School
Bachelor's Degree
Whitman College

Other Affiliations*

Annual Compensation*

Salary$512,500
Total Annual Compensation$512,500

Stock Options*

Restricted Stock Awards$4,166,667
All Other Compensation$373,532
Unexercisable Options72,971
Unexercisable Options Value$1,330,991
Total Value of Options$1,330,991
Total Number of Options72,971

Total Compensation*

Total Annual Cash Compensation$1,931,532
Total Short Term Compensation$512,500
Other Long Term Compensation$4,540,199
Total Calculated Compensation$6,931,528
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OREX:US $7.36 USD -0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
$4.3M
Scott D. Farmer Chief Executive Officer, Director and Member of Executive Committee
Cintas Corporation
$816.0K
David C. Dvorak Chief Executive Officer, President and Director
Zimmer Holdings, Inc.
$934.9K
Jean-Christophe Tellier Chief Executive Officer and Executive Director
UCB S.A.
--
Mark Christopher Trudeau Chief Executive Officer, President, Director and Member of Portfolio Committee
Mallinckrodt public limited company
$905.8K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OREXIGEN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.